2022 American Transplant Congress
Impact of Belatacept Conversion on Renal Function and Donor Specific Antibodies in Renal Transplant Recipients
Northwestern Memorial Hospital, Chicago, IL
*Purpose: Although associated with nephrotoxicity, calcineurin inhibitors (CNI) have historically been the cornerstone of immunosuppression. Belatacept, a co-stimulation blocker, is FDA-approved for de novo use…2022 American Transplant Congress
Kidney Transplant Recipients Not Reaching the Expected Post-Transplant Creatinine Range Most Likely Show Calcineurin-Inhibitor Nephrotoxicity Upon Histology
1University Hospital Zürich, Zürich, Switzerland, 2University Hospital Zurich, Zürich, Switzerland
*Purpose: Very recently, our own data suggested that approximately 25% of deceased-donor kidney transplant recipients (KTRs) and 10% of living-donor KTRs don’t reach the expected…2022 American Transplant Congress
A Novel Non-Invasive Urine Method for Assessment of Kidney Dysfunction
1Nephrosant, Brisbane, CA, 2NephroSant, San Francisco, CA
*Purpose: A recent cohort study of 10 869 living kidney donors from ImmPort highlighted that 14.7% have postdonation events unto 40 yrs later, relating to increased…2022 American Transplant Congress
Renal Allograft Outcomes of Very High KDPI vs High KDPI Donor Kidneys
Transplant Nephrology, Transplant Institute Loma Linda University, Loma Linda, CA
*Purpose: Since KDPI > 85 donor kidneys have been commonly used among older recipients, renal allograft outcomes of very high KDPI (≥95) donors have been…2022 American Transplant Congress
Early Post-Operative Thrombotic Microangiopathy in Deceased Donor Kidney Transplant: A Retrospective Case Series
*Purpose: Transplant associated thrombotic microangiopathy (TA-TMA) is characterized by endothelial injury along with thrombocytopenia, microangiopathic hemolytic anemia (MAHA) and kidney graft dysfunction. It can be…2022 American Transplant Congress
Long-Term Outcomes for Living Kidney Donors with Early Guideline-Concordant Follow-Up Care
*Purpose: Current guidelines recommend that living kidney donors receive annual lifelong follow-up to monitor kidney health. It is unclear whether early guideline-concordant care is associated…2022 American Transplant Congress
The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study
*Purpose: This study aimed to assess changes in renal function during the acute disease and up to three months after the onset of symptoms among…2022 American Transplant Congress
Optimizing Multimodal Pain Control Post Laparoscopic Living Donor Nephrectomy
1Jackson Memorial Hospital, Miami, FL, 2University of Miami/Jackson Memorial Hospital, Miami, FL
*Purpose: The purpose of this study is to examine the use of a multimodal pain regimen in our diverse population to better characterize short and…2022 American Transplant Congress
Dynamic Risk Prediction of Kidney Graft Failure After Deceased Donor Transplant
*Purpose: Identifying kidney transplant recipients at risk of graft failure allows for early intervention in clinical care. We developed a dynamic risk prediction model based…2022 American Transplant Congress
Belatacept Conversion in Proteinuric Kidney Transplant Recipients: Effects in a Prospective Trial and a Retrospective Cohort
*Purpose: Proteinuria after kidney transplantation is associated with worse allograft outcomes. B7-1 expression by podocytes has been linked to proteinuria by inducing podocyte migration which…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 19
- Next Page »